文献速递腹部MR

2型糖尿病对Gd-EOB-DTPA肝实质摄取的影响:人体重复研究

Effect of type 2 diabetes on Gd-EOB-DTPA uptake into liver parenchyma: replication study in human subjects.
PubMed 文献 · Abdom Radiol (NY) · 2021-06-23

该回顾性研究将94例接受Gd-EOB-DTPA增强MRI患者分为严重或未控制糖尿病组(胰岛素治疗和/或HbA1c≥8.4%,n=15)与对照组(n=79),发现糖尿病组肝脾比(LSR)和肝脏相对强化(REL)均显著低于对照组,提示严重或未控制糖尿病与肝实质Gd-EOB-DTPA摄取减少相关。

要点

  • 严重或未控制糖尿病组LSR和REL显著低于对照组。
  • 研究提示糖尿病可能减少肝细胞对Gd-EOB-DTPA的摄取。
  • 作者认为需进一步研究肝脏强化减低对临床诊断实践的影响。

核心结论

  • 严重或未控制糖尿病患者肝实质Gd-EOB-DTPA摄取减少,表现为LSR和REL显著降低。

研究设计与样本

  • 回顾性研究,共94例接受Gd-EOB-DTPA增强MRI的患者,分为严重或未控制糖尿病组(n=15,胰岛素治疗和/或HbA1c≥8.4%)与对照组(n=79),以LSR和REL代表Gd-EOB-DTPA肝摄取。

诊断标准与关键数值

  • 严重或未控制糖尿病组LSR为1.74±0.26,对照组为1.98±0.31,p=0.007。
  • 严重或未控制糖尿病组REL为0.69±0.23,对照组为0.87±0.31,p=0.005。

临床应用与阅片要点

  • 作者认为需进一步研究肝脏强化减低对临床诊断实践的影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) is a contrast agent for magnetic resonance imaging (MRI), which specifically taken up by hepatocytes through organic anion-transporting polypeptides (OATPs). Previous research in mice has shown that type 2 diabetes is associated with reduced uptake of Gd-EOB-DTPA into the liver parenchyma, reflecting reduced expression of OATP. Since considerable differences in OATP expression exist between mice and humans, human studies are necessary to clarify the effect of diabetes to Gd-EOB-DTPA uptake. The purpose of this study was to validate the effect of diabetes to Gd-EOB-DTPA liver uptake by a confirmatory study in humans.

METHODS: Patients who underwent Gd-EOB-DTPA-enhanced MRI were retrospectively reviewed and divided into two groups: severe or uncontrolled diabetic group (patients with insulin therapy and/or HbA1c ≥ 8.4%) and the control group. Liver-to-spleen ratio (LSR) and relative enhancement of the liver (REL) were calculated to represent Gd-EOB-DTPA liver uptake.

RESULTS: A total of 94 patients fulfilled the criteria. The severe or uncontrolled diabetic group (n = 15) showed significantly lower LSR (1.74 ± 0.26 vs. 1.98 ± 0.31, p = 0.007) and REL (0.69 ± 0.23 vs. 0.87 ± 0.31, p = 0.005), compared to the control group (n = 79).

CONCLUSION: Our study revealed decreased uptake of Gd-EOB-DTPA into liver parenchyma in the severe or uncontrolled diabetic patients. Further studies to determine the impact of the reduced liver enhancement on clinical diagnostic practice will be needed.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Kumasaka S, Seki Y, Kumasaka Y, et al. Effect of type 2 diabetes on Gd-EOB-DTPA uptake into liver parenchyma: replication study in human subjects. Abdom Radiol (NY). 2021. PMID: 34164726. doi:10.1007/s00261-021-03184-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。